News | September 12, 2024
AGC and Medinet sign agreement for cell therapy CDMO business
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
EBITDA for Q1 FY25 is at Rs. 100 crore compared to Rs. 32 crore in the previous year
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Bluecrux's digital supply chain twin technology, Axon, plays a critical role in Sanofi's digital supply chain transformation.
The award recognizes powerful science–industry collaborations for social good
Subscribe To Our Newsletter & Stay Updated
